Published in Genomics on November 15, 1999
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest (2000) 7.06
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09
Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci U S A (2001) 1.80
PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin (Shanghai) (2011) 1.35
Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci U S A (2012) 1.33
AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLoS One (2008) 1.32
Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord (2007) 1.29
The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol Neurodegener (2009) 1.23
PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia. PLoS One (2010) 1.11
Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1{alpha} via the N-terminal pathway. J Biol Chem (2010) 1.08
Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging? J Aging Res (2012) 1.08
Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha. Biochem J (2003) 1.02
Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci (2014) 1.01
PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond. Prog Neurobiol (2011) 1.00
Effect of endurance exercise training on Ca2+ calmodulin-dependent protein kinase II expression and signalling in skeletal muscle of humans. J Physiol (2007) 0.97
Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf. PLoS One (2012) 0.96
PGC-1alpha inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells. PLoS One (2007) 0.96
Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis (2012) 0.94
Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet (2005) 0.91
Novel small-molecule PGC-1α transcriptional regulator with beneficial effects on diabetic db/db mice. Diabetes (2012) 0.84
PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy. Neurobiol Dis (2014) 0.82
The role of the PGC1α Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. PPAR Res (2009) 0.82
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol (2014) 0.81
Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate. Nutr Metab (Lond) (2012) 0.81
Regulation of PPARγ Coactivator-1α Function and Expression in Muscle: Effect of Exercise. PPAR Res (2010) 0.80
Effects of caffeine on metabolism and mitochondria biogenesis in rhabdomyosarcoma cells compared with 2,4-dinitrophenol. Nutr Metab Insights (2012) 0.80
Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes. Ann Hum Genet (2014) 0.80
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discov (2016) 0.80
Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver. J Biol Chem (2011) 0.79
PPARγ and PGC-1α as therapeutic targets in Parkinson's. Neurochem Res (2014) 0.79
Regulation of PGC-1α Isoform Expression in Skeletal Muscles. Acta Naturae (2015) 0.77
The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes. BMC Cancer (2012) 0.76
The 482Ser of PPARGC1A and 12Pro of PPARG2 Alleles Are Associated with Reduction of Metabolic Risk Factors Even Obesity in a Mexican-Mestizo Population. Biomed Res Int (2015) 0.75
Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes. Mitochondrion (2014) 0.75
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2001) 4.21
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet (2001) 1.79
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study. Ann Epidemiol (1999) 1.50
Turnover of lipoprotein (a) in man. J Clin Invest (1980) 1.48
Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest (1983) 1.48
The complement system: a pathway linking host defence and adipocyte biology. Eur J Clin Invest (1999) 1.41
Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res (1990) 1.33
PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia (2006) 1.32
Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans. J Lipid Res (1997) 1.29
Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis (1985) 1.25
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest (1983) 1.22
Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol (1996) 1.20
Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1994) 1.19
Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest (1982) 1.17
Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1992) 1.14
Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem (1986) 1.10
Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus. J Lipid Res (1998) 1.10
Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol (1995) 1.09
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest (1987) 1.07
Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med (1999) 1.06
Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans. Diabetologia (2010) 1.05
Lipolysis produces changes in the immunoreactivity and cell reactivity of very low density lipoproteins. J Clin Invest (1979) 1.04
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med (2011) 1.02
Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation. J Biol Chem (1978) 1.01
Characterization of human high density lipoproteins by zonal ultracentrifugation. J Biol Chem (1980) 1.01
African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (1998) 1.00
Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med (1990) 1.00
Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. Metabolism (1990) 0.99
Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (1995) 0.98
Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol (2001) 0.97
Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. Prev Med (2000) 0.97
Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2000) 0.97
Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures. J Clin Invest (1983) 0.96
An enzymatic method for the determination of the initial rate of cholesterol esterification in human plasma. J Lipid Res (1976) 0.95
Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim Biophys Acta (1979) 0.95
Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet (1994) 0.94
Viscosity of culture medium as a regulator of synthesis and secretion of very low density lipoproteins by cultured hepatocytes. J Biol Chem (1982) 0.94
Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol (2004) 0.92
Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet (1991) 0.92
The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Int J Obes (Lond) (2006) 0.91
Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels. JAMA (1987) 0.91
Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet (1995) 0.91
Lipoprotein[a] as a risk factor for preclinical atherosclerosis. Arterioscler Thromb (1993) 0.91
Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis (1990) 0.91
Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia (1998) 0.89
Inheritance and expression of a transgene insert in an aneuploid tobacco line. Mol Gen Genet (1994) 0.88
Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. Metabolism (1990) 0.87
Iron stores, liver transaminase levels and metabolic risk in healthy teenagers. Eur J Clin Invest (2009) 0.87
Receptors for homologous plasma lipoproteins on a rat hepatoma cell line. J Lipid Res (1983) 0.87
Salzburg Skiing for the Elderly Study: changes in cardiovascular risk factors through skiing in the elderly. Scand J Med Sci Sports (2011) 0.87
Characterization of lipoprotein in a kindred with familial hypercholesterolemia. J Lipid Res (1982) 0.87
The uncoupling protein-3 gene is transcribed from tissue-specific promoters in humans but not in rodents. J Biol Chem (2000) 0.86
The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. Int J Obes Relat Metab Disord (2000) 0.86
Lipoprotein binding to cultured human hepatoma cells. J Clin Invest (1987) 0.86
IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J Allergy Clin Immunol (2000) 0.86
Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis (1988) 0.86
Enolases are highly conserved fungal allergens. Int Arch Allergy Immunol (1997) 0.85
Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. J Lipid Res (1992) 0.85
Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men. N Engl J Med (1983) 0.85
Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. Clin Chem (1988) 0.85
Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans. J Intern Med (2008) 0.85
Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover. Atherosclerosis (1983) 0.85
Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler Thromb Vasc Biol (1998) 0.84
The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 0.84
Uncoupling protein-3 gene expression: reduced skeletal muscle mRNA in obese humans during pronounced weight loss. Diabetologia (1999) 0.84
Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler Thromb Vasc Biol (1996) 0.83
Zonal ultracentrifugation. Methods Enzymol (1986) 0.83
A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis (1995) 0.83
Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism (1995) 0.83
Postprandial lipemia: reliability in an epidemiologic field study. Am J Epidemiol (1992) 0.82
The effect of short-term feeding of a high carbohydrate diet on HLD subclasses in normal subjects. Metabolism (1981) 0.82
Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. Am J Cardiol (1986) 0.82
The role of lecithin:cholesterol acyltransferase for the low density lipoprotein composition and specific binding to the B receptor. Biochim Biophys Acta (1982) 0.82